A trial looking at MTL-005 for head and neck cancers (MOREX)

Please note

This trial is no longer recruiting patients. We hope to add results when they are available.

Overview

Cancer types:

Head and neck cancers, Laryngeal cancer, Mouth and oropharyngeal cancer, Nasal and paranasal sinus cancer , Salivary gland cancer

Status:

Closed

Phase:

Phase 1

Details

This trial is looking at a drug called MTL-005 alongside a combination of chemotherapy and radiotherapy (chemoradiation) for head and neck cancers. This trial has 2 parts. In the 1st part people were having radiotherapy to control their symptoms (palliative radiotherapy). Part 1 has now closed. Part 2 is for people with head and neck cancer whose cancer has spread to surrounding tissue (locally advanced disease).

Recruitment start: 30 August 2013

Recruitment end: 20 March 2018